Biostar Pharmaceuticals, Inc. Assets, Fair Value Disclosure
Biostar Pharmaceuticals, Inc. had Assets, Fair Value Disclosure of $38.90 thousand as of 2015-12-31, per its 10-K filed 2016-04-14.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:AssetsFairValueDisclosure · last filed 2016-04-14
- 2015-12-31: Assets, Fair Value Disclosure $38.90K.
- 2015-09-30: Assets, Fair Value Disclosure $9.56M.
- 2015-06-30: Assets, Fair Value Disclosure $10.17M.
- 2015-03-31: Assets, Fair Value Disclosure $12.53M.
| Period end | Assets, Fair Value Disclosure |
|---|---|
| 2015-12-31 | $38.90K 10-K · filed 2016-04-14 |
| 2015-09-30 | $9.56M 10-Q · filed 2015-11-23 |
| 2015-06-30 | $10.17M 10-Q · filed 2015-08-19 |
| 2015-03-31 | $12.53M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $11.46M 10-K · filed 2016-04-14 |
| 2013-12-31 | $9.90M 10-K · filed 2015-04-15 |